Navigation Links
NOVAVAX and University of Massachusetts Medical School Publish Preclinical Safety and Efficacy Study of a Respiratory Syncytial Virus (RSV) Virus-like Particle (VLP) Vaccine Candidate
Date:12/22/2010

disease from the molecular level to large-scale clinical trials. Basic and clinical research has led to new approaches for diagnosis, treatment and prevention of disease. Visit www.umassmed.edu for additional information.

About Novavax

Novavax, Inc. is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company's website: www.novavax.com.

Cautionary Note Regarding Forward-Looking Statements

Statements herein relating to the results of preclinical tests are forward-looking statements. Novavax cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. We caution readers not to place significant reliance on forward-looking statements contained in this release. Factors that may cause actual results to differ materially from the results discussed in forward-looking statements are contained in Novavax's filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov, including the factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2009, as updated by our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2010, June 30, 2010, and September 30, 20
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NOVAVAX Awarded Nearly $1 Million in Grants from IRS Under Qualifying Therapeutic Discovery Project
2. NOVAVAX to Present at the Immunotherapeutics and Vaccine (IMVAC) Summit
3. NOVAVAX Elects Richard H. Douglas to its Board of Directors
4. Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
5. Novavax Announces Manufacturing Management Appointments
6. Novavax Announces Publication of a Pre-clinical Study with its Pandemic 2009 H1N1 Influenza Virus-Like Particle (VLP) Vaccine
7. NOVAVAX Completes Enrollment of Pivotal H1N1 Influenza Vaccine Clinical Trial in Mexico
8. NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference
9. NOVAVAX to Present at Phacilitate Vaccine Forum Washington 2010
10. NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate
11. NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... -- In the farthest reaches of the Amazon rainforest, the ... together in a quest to save their ancestral knowledge ... May in a remote village on the frontier divide ... over two years work and culminated in the production ... an Amazonian tribe. The 500-page repository details medicinal plants ...
(Date:7/7/2015)... ... July 07, 2015 , ... uBiome, the leading microbial ... $100,000 of microbiome sampling kits and full 16S laboratory analysis. The goal is to ... winner will also have access to their own dashboard, enabling them to view and ...
(Date:7/7/2015)... ... July 07, 2015 , ... Currently ... system was developed to solve many of the complex logistical and data ... that involve multiple clinical sites and/or remote data coordination centers. , CentrePoint ...
(Date:7/6/2015)... ... July 06, 2015 , ... Proove Biosciences , ... Pain Management Medical Advisory Board meeting in Palm Springs, California. At the bi-annual ... team to discuss new clinical practice and research ideas. The Board also discussed ...
Breaking Biology Technology:Amazonian Tribe Creates First Encyclopedia of Indigenous Medicine 2Amazonian Tribe Creates First Encyclopedia of Indigenous Medicine 3Amazonian Tribe Creates First Encyclopedia of Indigenous Medicine 4uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 2uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 3ActiGraph Launches CentrePoint Cloud-based Study Management Software Platform 2ActiGraph Launches CentrePoint Cloud-based Study Management Software Platform 3Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 2Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 3
... 3 Neurobiological,Technologies, Inc. (NTI(R)) (Nasdaq: ... quarterly royalty payment of approximately $2.0 million ... Memantine for the treatment of,moderate-to-severe Alzheimer,s disease. ... quarterly royalty payments on certain,sales of Memantine ...
... 3 Cepheid (Nasdaq:,CPHD) today announced that ... to,acquire Stretton Scientific Limited, a privately held ... based in,Stretton, England. Stretton Scientific currently distributes ... science products, to,a broad group of medical ...
... Cardiac Science,(Nasdaq: CSCX ) a ... and informatics products, announced the,appointment today of ... and Chief,Operating Officer., (Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO ... to build our strategic capabilities at a,senior ...
Cached Biology Technology:Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific 2Cepheid Accelerates Direct Sales Channel in UK With Pending Acquisition of Medical Distributor Stretton Scientific 3Cardiac Science Appoints Dave Marver as Chief Operating Officer 2Cardiac Science Appoints Dave Marver as Chief Operating Officer 3
(Date:6/25/2015)... SALT LAKE CITY , June 25, 2015 /PRNewswire/ ... the first steps toward a healthier, happier life. That,s ... app is designed to do. The cutting-edge, portable health ... and offers real-life solutions to help improve your lifestyle ... Sellers Association awards dinner and gala Wednesday night, USANA,s ...
(Date:6/24/2015)... Calif. , June 24, 2015  Synaptics ... of human interface solutions, today announced that Sharp ... to provide secure authentication for its latest flagship ... reached more than 200 million shipments of its ... Sharp reinforces Synaptics, strength, scalability and leadership in ...
(Date:6/23/2015)... , June 22, 2015 ... the addition of the "Body-Worn Temperature Sensors ... Trends and Forecast 2014 - 2020" report ... strategic analysis of the global body-worn temperature sensors ... been segmented on the basis of types, care ...
Breaking Biology News(10 mins):@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... in Colombia,s Cerrejn coal mine by researchers from the Smithsonian ... Natural History helps to explain the origin of one of ... Cerrejonemys wayuunaiki takes its genus name from Cerrejn, ... spoken by the Wayuu people who live on the Guajira ...
... if you are making cellulosic ethanol, you want less lignin ... are using pyrolytic methods, you want more lignin because lignin ... or minimize lignin content, an understanding of lignin synthesis is ... adaptation to life on land, as it strengthens plant cell ...
... through which it can protect itself against newly-developing cancer ... in our organs every day. Once tumours have developed, ... from the immune system. Scientists from the research group ... (HZI) in Braunschweig have now succeeded to reveal a ...
Cached Biology News:Convergent evolution in lignin biosynthesis: Tools for re-engineering biomass composition 2The immune system's guard against cancer 2The immune system's guard against cancer 3
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
Mouse monoclonal [7C6] to Bcr-abl ( Abpromise for all tested applications). SwissProtID: P11274...
Affinity Purified Rabbit Anti-mouse sRANKL Biotinylated Polyclonal Antibody...
Rabbit polyclonal to FOXJ2 ( Abpromise for all tested applications). entrezGeneID: 55810 SwissProtID: Q9P0K8...
Biology Products: